PharmaShots | Incisive News in 3 Shots

Subscribe Now

dMMR Regulatory

Merck Reports the US FDA's Acceptance of Keytruda's sBLA for Review to Treat MSI-H/dMMR Advanced Endometrial Carcinoma

Merck Reports the US FDA's Acceptance of Keytruda's sBLA for Review to Treat MSI-H/dMMR Advanced Endometrial Carcinoma

August 11, 2021

Merck and Eisai's Keytruda (pembrolizumab) + Lenvima (lenvatinib) Receive the US FDA's Approval for the Treatment of Advanced Endometrial Carcinoma

Merck and Eisai's Keytruda (pembrolizumab) + Lenvima (lenvatinib) Receive the US FDA's Approval for the Treatment of Advanced Endo...

July 22, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us